Example: Heart Attack

Search clinical trials for: Machine learning algorithm

Total 10000 results

NCT05849727

Terminated

A Clinical Study of TQH3821 Tablets in the Treatment of Treated Rheumatoid Arthritis

Rheumatoid Arthritis
NCT06854354

Completed

Intervention for Human Papillomavirus Vaccine Acceptance in Mexican Mothers

Papillomavirus Infections | Papillomavirus Vaccines
NCT01432340

Completed

Seasonal Influenza Vaccine Effectiveness Study in Kenya

Influenza | Severe Acute Respiratory Illness | Influenza Like Illness
NCT00139113

Completed

Immunogenicity Study of an Inactivated Hepatitis A Vaccine in Infants and Young Children

Hepatitis A
NCT02961595

Completed

Live Enterovirus Vaccine and Type 1 Diabetes

Type 1 Diabetes | Prediabetic State | Enterovirus Infection
NCT02415387

Completed

Typhoid Vaccine in Testing Response to Immune Stress in Patients With Stage I-IIIA Breast Cancer (IMPACT)

Depression | Recurrent Breast Carcinoma | Stage IIIA Breast Cancer | Stage IA Breast Cancer | Stage IB Breast Cancer | Stage IIA Breast Cancer | Stage IIB Breast Cancer | Cognitive Side Effects of Cancer Therapy
NCT05772286

Active, not recruiting

Clinical Trial to Evaluate the Safety and Immunogenicity of Recombinant HIV-1 Envelope Protein SOSIP v8.2 763 Vaccine, Adjuvanted With MPLA Liposomes, in Healthy, HIV-Uninfected Adults (HIVAC-FOUND)

Healthy
NCT05157178

Active, not recruiting

Immunogenicity Study of the Covid-19 (Recombinante) Vaccine With a 4 or 8 Week Interval Between the First Doses.

COVID-19
NCT00583024

Completed

Phase II Study of Adenovirus/PSA Vaccine in Men With Hormone - Refractory Prostate Cancer (APP22)

Hormone Refractory Prostate Cancer
NCT03886688

Completed

HEC53856 Phase 1 Study - Single and Multiple Oral Dosing in Healthy Volunteers

Healthy
NCT05193279

Withdrawn

Safety and Immunogenicity of SCB-2019 in Children <18 Years of Age

COVID-19
NCT04806113

Completed

COVID-19 Vaccine in Immunosuppressed Adults With Autoimmune Diseases (COVIAAD)

Covid19 | Rheumatic Diseases | Rheumatoid Arthritis | SLE
NCT05774418

Completed

Evaluation of the Impact of the Anti COVID-19 Vaccination Campaign Addressed to the Employees of an Italian Hospital.

COVID-19
NCT03287427

Completed

MYPHISMO: MYB and PD-1 Immunotherapies Against Multiple Oncologies Trial (MYPHISMO)

Adenoid Cystic Carcinoma | Colorectal Cancer
NCT05059301

Completed

A Study of 3 Lots of an Investigational Vaccine Against Respiratory Syncytial Virus (RSV) in Adults Aged 60 Years and Above

Respiratory Syncytial Virus Infections
NCT04691947

Completed

Safety and Immunogenicity of Two Different Strengths of the Inactivated COVID-19 Vaccine ERUCOV-VAC (ERUCOV-VAC)

COVID-19 Vaccine
NCT03039790

Completed

Long-Term Immunogenicity of the Norovirus GI.1/GII.4 Bivalent Virus-like Particle (VLP) Vaccine (NoV Vaccine) in Adults

Healthy Volunteers | Norovirus
NCT04107961

Withdrawn

A Study to Assess Safety and Efficacy of a Leishmania Vaccine to Prevent Post Kala Azar Dermal Leishmaniasis (PKDL) (LEISH3)

Post-kala-azar Dermal Leishmaniasis
NCT05136833

Withdrawn

Evaluation of Efficacy and Safety of the Concomitant of RUTI® Immunotherapy With the Standard Treatment in TB Patients (CONSTAN)

Tuberculosis
NCT05234333

Completed

COVID-19 Vaccines Associated Malaise

Vaccine Adverse Reaction
NCT02009800

Completed

ICI-VPH: Impact of HPV Immunisation Schedules Against HPV (ICI-VPH)

Human Papillomavirus Infections
NCT05330624

Active, not recruiting

Immunogenicity and Safety of Subunit Vaccine of Plague Vaccine With Two Immunization Regimens

Plague
NCT04636697

Active, not recruiting

Study of a Recombinant Coronavirus-Like Particle COVID-19 Vaccine in Adults

SARS-CoV-2 Infection
NCT03412786

Completed

Bcl-XL_42-CAF09b Vaccination for Patients With Prostate Cancer With Lymph Node Metastases

Prostate Cancer
NCT01545050

Terminated

Dose Ranging Study of BMS-945429 in Subjects With Moderate to Severe Crohn's Disease

Crohn's Disease
NCT00604175

Completed

Safety of and Immune Response to the Human Papillomavirus (HPV) Vaccine in HIV-Infected Women

HIV Infections | Sexually Transmitted Diseases
NCT03383055

Completed

CMV-MVA Triplex Vac.Enhance Adap. NK Cell Recon. After Auto HSCT in pt Lymphoid Malig

Lymphoma | Multiple Myeloma
NCT04497662

Completed

Study to Evaluate the Safety, Tolerability, Pharmacokinetics, and Pharmacodynamics of Single Ascending Doses of KPL-404 in Healthy Subjects

Healthy Volunteers
NCT02561195

Completed

A Study To Investigate Two 3-dose Schedules Of A Clostridium Difficile Vaccine In Healthy Adults Aged 65 to 85 Years

Clostridium Difficile Associated Disease
NCT02046148

Completed

Safety and Immunogenicity of a Trivalent Group B Streptococcus Vaccine in Healthy Pregnant Women

Streptococcus Agalactiae | GBS Disease
NCT01266993

Completed

Persistence and Booster Study of GSK Biologicals' Meningococcal Vaccine (GSK134612) in Healthy Children

Infections, Meningococcal | Meningococcal Vaccines
NCT04618640

Unknown

To Evaluate the Immunogenicity and Safety of DTaP-IPV Vaccine Administered as a Boosting Dose to Healthy Children of 4-6 Years (Aladdin)

Pertussis | Tetanus | Diphtheria | Poliomyelitis
NCT03072030

Completed

International Multicenter Study of the Immunogenicity of Medicinal Product GamEvac-Combi

Ebola Virus Disease | Prevention
NCT03723837

Completed

Persistence of IPV Immunity

Poliomyelitis
NCT00841399

Completed

Safety and Efficacy Study of HER2/Neu (E75) Vaccine in Node-Positive Breast Cancer Patients

Breast Cancer
NCT00854789

Completed

Safety and Efficacy Study of HER2/Neu (E75) Vaccine in Breast Cancer

Breast Cancer
NCT03430388

Completed

Yellow Fever Vaccine in Patients With Rheumatic Diseases

Rheumatoid Arthritis | Systemic Sclerosis | Granulomatosis With Polyangiitis | Juvenile Idiopathic Arthritis | Sjogren's Syndrome | Takayasu Arteritis | Spondyloarthritis | Juvenile Dermatomyositis | Mixed Connective Tissue Disease | Systemic Lupus
NCT03042741

Unknown

Vaccine Against Atherosclerosis in Patients With Overweight Problems or Obesity (V6)

Atherosclerosis
NCT00971321

Completed

Safety, Immunogenicity Study of GSK Biologicals' Pandemic Influenza Candidate Vaccine (H1N1) (GSK2340272A)

Influenza
NCT00989612

Completed

Study to Evaluate Immunogenicity and Safety of an Investigational Influenza Vaccine (H1N1)

Influenza
NCT03158038

Completed

Study to Evaluate the Safety of 1 New 6:2 Influenza Virus Reassortant in Adults for the 2017-2018 Season (FluMist)

Healthy | Influenza
NCT01014091

Terminated

Study to Evaluate the Safety and Immunogenicity of GSK Biological Pandemic Candidate Influenza Vaccine (H1N1) in Children

Influenza
NCT00443157

Completed

Meningococcal B Vaccination in University Students (MNB3)

Neisseria Meningitidis Serogroup B
NCT02297542

Unknown

Immune Response to High-Dose vs. Standard Dose Influenza Vaccine

Elderly Immune System
NCT01800071

Completed

A Phase Ib Trial of MVA-EBNA1/LMP2 Vaccine in Nasopharyngeal Carcinoma

Nasopharyngeal Cancer | Epstein Barr Virus Infections
NCT01514708

Completed

The Safety and Immune Response to Influenza Vaccination in Pregnant Women

Influenza
NCT00385840

Completed

Study to Evaluate the Immunogenicity and Safety of a Second Vaccination With the Adjuvanted Influenza Vaccine Candidate

Influenza
NCT00964158

Completed

Safety and Immunogenicity Study of GSK Biologicals' Pandemic Influenza Candidate Vaccine (H1N1) (GSK2340272A)

Influenza
NCT00928785

Completed

Study Comparing a Tdap-IPV Combined Vaccine With a Tetanus Monovalent Vaccine in Healthy Adults

Healthy
NCT00377585

Completed

Demonstrate the Superiority of the Immune Response of Adjuvanted Influenza Vaccine Induced in an Adult Population

Influenza

Search clinical trials for: Machine learning algorithm

Sponsors and Collaborators

Medical Conditions

Drug Interventions

Conditions

Rare Diseases

Drug Interventions

Dietary Supplements

Sponsor/Collaborators

Locations